Mitochondrial Myopathy
8
2
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy
Oxidative Capacity and Exercise Tolerance in Ambulatory SMA
Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy
The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease
Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia
Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy